Posted in | News

Saint-Gobain Commences Production at First Plasterboard Plant in Russia

Already present in the habitat and construction markets in Russia through its Industrial Mortars and Insulation businesses, Saint-Gobain has just started production at its first plasterboard plant in the country. The new site - which also contains a gypsum quarry - is located close to the village of Gomzovo, in the Nizhny Novgorod region.

The plant was officially opened on July 10, 2013 by Pierre-André de Chalendar, Chairman and CEO of Saint-Gobain, at a ceremony attended by representatives from the local and regional authorities.

The new state-of-the-art plant will strengthen Saint-Gobain's position in the Russian habitat and construction markets and meet growing demand for plasterboard in the country. The site represents an investment of around € 70 million, and has a workforce of 87 employees.

"The start-up of this new plant is an important step in the Group's development within the Russian habitat and construction markets," said Pierre-André de Chalendar. "With its unique portfolio of products and solutions, Saint-Gobain serves rapidly growing construction markets worldwide. Russia's climate, its rising purchasing power and pressing need for housing means that it's a country with great potential for the Group."

More about Saint-Gobain

Saint-Gobain, the world leader in the habitat and construction markets, designs, manufactures and distributes building materials, providing innovative solutions to the challenges of growth, energy efficiency and environmental protection. With 2012 sales of €43.2 billion, Saint-Gobain operates in 64 countries and has nearly 193,000 employees. For more information about Saint-Gobain, please visit http://www.saint-gobain.com.

Saint-Gobain has been present in CIS since the early 1990's. The Group currently employs 3,200 people at eight production plants in this region.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.